T39.312 Poisoning by propionic acid derivatives, intentional self-harm

Name of the Condition

• Poisoning by propionic acid derivatives, intentional self-harm (ICD-10-CM Code: T39.312)

Summary

This condition involves intentional self-harm through poisoning by propionic acid derivatives, a class of nonsteroidal anti-inflammatory drugs (NSAIDs) commonly used for pain relief, inflammation reduction, and fever management. The code applies to cases where these substances are ingested with the intent to cause self-harm, leading to toxicity or adverse effects.

Causes

Intentional self-harm poisoning by propionic acid derivatives typically results from deliberate ingestion of excessive doses of these medications. This may occur as part of a suicide attempt or self-injurious behavior. The substances involved include drugs like ibuprofen or naproxen, which are widely available and may be misused in harmful quantities.

Risk Factors

• Mental health conditions such as depression, anxiety, or suicidal ideation.
• History of prior self-harm or suicide attempts.
• Access to medications, including over-the-counter NSAIDs.
• Substance use disorders or concurrent use of other harmful substances.
• Social or environmental stressors contributing to self-harm behaviors.

Symptoms

• Gastrointestinal: nausea, vomiting, abdominal pain, or bleeding.
• Neurological: dizziness, headache, confusion, or seizures.
• Renal: decreased urine output or acute kidney injury.
• Metabolic: electrolyte imbalances or metabolic acidosis.
• Cardiovascular: tachycardia, hypotension, or arrhythmias.

Diagnosis

Diagnosis requires a thorough clinical evaluation, including a detailed history of the ingestion event, physical examination, and laboratory testing. Toxicology screens may confirm the presence of propionic acid derivatives. Imaging or other tests may assess organ damage, such as renal or gastrointestinal injury. Documentation of intent is critical for accurate coding.

Treatment Options

Treatment focuses on stabilizing the patient, preventing further absorption of the substance, and managing complications. This may include activated charcoal, gastric lavage, or supportive care like intravenous fluids. Specific antidotes are not available, so management is symptomatic. Psychiatric evaluation and intervention are essential for addressing the underlying self-harm behavior.

Prognosis and Follow-Up

Prognosis depends on the amount ingested, time to treatment, and presence of complications. Early intervention improves outcomes. Follow-up care includes monitoring for organ damage and arranging psychiatric support to reduce the risk of recurrence. Long-term management may involve therapy, medication, or crisis intervention.

Complications

• Gastrointestinal bleeding or perforation.
• Acute kidney injury or renal failure.
• Seizures or neurological impairment.
• Metabolic disturbances (e.g., acidosis).
• Cardiovascular instability or arrhythmias.
• Psychological sequelae, including ongoing suicidal ideation.

Lifestyle & Prevention

• Secure storage of medications to limit access.
• Education on proper dosing and safe use of NSAIDs.
• Mental health support and crisis resources for at-risk individuals.
• Regular monitoring of high-risk patients for medication misuse.
• Encouraging open communication about self-harm concerns.

When to Seek Professional Help

Seek immediate medical attention if self-harm with medications is suspected or confirmed. Signs of poisoning, such as severe nausea, vomiting, dizziness, or altered mental status, require urgent care. Psychiatric evaluation is necessary to address underlying issues and prevent future incidents.

Tips for Medical Coders

Document the intent (intentional self-harm) clearly in the medical record, as this determines the use of T39.312. Include details about the substance ingested, timing, and clinical findings to support the diagnosis. Ensure the code aligns with the documented intent and clinical scenario, avoiding ambiguity in the record.